January 9, 2025 - 17:10

In a significant move to enhance its portfolio, Synaffix, a leader in antibody-drug conjugate (ADC) technology, has entered into a new licensing agreement with Boehringer Ingelheim. This partnership allows Boehringer to leverage Synaffix's advanced ADC technologies for a specified number of cancer targets, although the exact details regarding the number of targets remain confidential.
This agreement marks a strategic step for Synaffix as it continues to build on its momentum from last year, when it secured several partnerships. Additionally, Synaffix has expanded its collaboration network by forming a technology licensing deal with Mitsubishi Tanabe Pharma in Japan. These developments underscore Synaffix's commitment to advancing cancer treatment options through innovative ADC technologies.
As the landscape of cancer therapeutics evolves, this collaboration with Boehringer Ingelheim is poised to accelerate the development of novel ADC therapies, potentially leading to more effective treatment solutions for patients battling cancer.
June 7, 2026 - 04:08
A Look At Spotify Technology (NYSE:SPOT) Valuation After Recent Share Price VolatilitySpotify Technology (NYSE:SPOT) is drawing renewed attention from investors after a period of notable share price swings. The stock recently closed at $496.95, reflecting a complex picture of...
June 6, 2026 - 06:09
Carroll's Jaydon Capers signs with Missouri University of Science and Technology for volleyballCarroll High School senior Jaydon Capers has officially committed to continuing her volleyball career at Missouri University of Science and Technology. The standout athlete made her decision...
June 5, 2026 - 23:02
Why investors should pay attention to this ‘revolutionary’ technologyAptus Capital Advisors head of equities and portfolio manager David Wagner recently appeared on `The Claman Countdown` to break down the current market sell-off and offer guidance to investors....
June 5, 2026 - 10:54
Startup helps retailers track their products in real-timeA startup called Cartesian is offering retailers a new way to track their products in real time, using a system that originated from research at the Massachusetts Institute of Technology. The...